In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptides

Xianzheng Zhou, Ussama M. Abdel-Motal, Louise Berg, Mikael Jondal

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Cytotoxic T lymphocytes (CTL) recognize target antigens as short peptides presented by major histocompatibility complex class I molecules (MHC‐I). Externally added peptides can sensitize target cells by binding directly to MHC‐I without any need for internal processing. Those which are similar in length to endogenously processed peptides are more potent in this respect than slightly longer peptides. Peptide MHC‐I interactions can also be reflected as upregulation of MHC‐I in vitro on certain cells. We have compared the capacity of Db, Kb‐ and Ld‐binding peptides, which are slightly different in length, to up‐regulate MHC‐I in vitro with their immunogenicity in vivo, in relation to generation of CTL responses. A clear correlation between these two different functions was found. We have also modified a 9‐mer Db‐binding peptide by adding cystein to the amino terminus and lysine to the amino‐ or carboxy terminus and studied the effects on MHC‐I up‐regulation and in vivo immunogenicity. Cystein and lysine contain reactive groups which are likely to influence the binding of modified peptides into the antigen‐binding groove of Db. These small modifications of the optimal 9‐mer peptide strongly influenced their functions but still there was a correlation between MHC‐I up‐regulation and CTL responses. Up‐regulation of MHC‐I in vitro may reflect a capacity of peptides to accumulate on the surface of particular antigen‐presenting cells in vivo.

Original languageEnglish
Pages (from-to)3085-3090
Number of pages6
JournalEuropean Journal of Immunology
Volume22
Issue number12
DOIs
Publication statusPublished - 1992
Externally publishedYes

Fingerprint

Cytotoxic T-Lymphocytes
Major Histocompatibility Complex
Up-Regulation
Peptides
Lysine
In Vitro Techniques
Antigens

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{48d985cbc39a453d9b1408c525ecb254,
title = "In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptides",
abstract = "Cytotoxic T lymphocytes (CTL) recognize target antigens as short peptides presented by major histocompatibility complex class I molecules (MHC‐I). Externally added peptides can sensitize target cells by binding directly to MHC‐I without any need for internal processing. Those which are similar in length to endogenously processed peptides are more potent in this respect than slightly longer peptides. Peptide MHC‐I interactions can also be reflected as upregulation of MHC‐I in vitro on certain cells. We have compared the capacity of Db, Kb‐ and Ld‐binding peptides, which are slightly different in length, to up‐regulate MHC‐I in vitro with their immunogenicity in vivo, in relation to generation of CTL responses. A clear correlation between these two different functions was found. We have also modified a 9‐mer Db‐binding peptide by adding cystein to the amino terminus and lysine to the amino‐ or carboxy terminus and studied the effects on MHC‐I up‐regulation and in vivo immunogenicity. Cystein and lysine contain reactive groups which are likely to influence the binding of modified peptides into the antigen‐binding groove of Db. These small modifications of the optimal 9‐mer peptide strongly influenced their functions but still there was a correlation between MHC‐I up‐regulation and CTL responses. Up‐regulation of MHC‐I in vitro may reflect a capacity of peptides to accumulate on the surface of particular antigen‐presenting cells in vivo.",
author = "Xianzheng Zhou and Abdel-Motal, {Ussama M.} and Louise Berg and Mikael Jondal",
year = "1992",
doi = "10.1002/eji.1830221209",
language = "English",
volume = "22",
pages = "3085--3090",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "12",

}

TY - JOUR

T1 - In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptides

AU - Zhou, Xianzheng

AU - Abdel-Motal, Ussama M.

AU - Berg, Louise

AU - Jondal, Mikael

PY - 1992

Y1 - 1992

N2 - Cytotoxic T lymphocytes (CTL) recognize target antigens as short peptides presented by major histocompatibility complex class I molecules (MHC‐I). Externally added peptides can sensitize target cells by binding directly to MHC‐I without any need for internal processing. Those which are similar in length to endogenously processed peptides are more potent in this respect than slightly longer peptides. Peptide MHC‐I interactions can also be reflected as upregulation of MHC‐I in vitro on certain cells. We have compared the capacity of Db, Kb‐ and Ld‐binding peptides, which are slightly different in length, to up‐regulate MHC‐I in vitro with their immunogenicity in vivo, in relation to generation of CTL responses. A clear correlation between these two different functions was found. We have also modified a 9‐mer Db‐binding peptide by adding cystein to the amino terminus and lysine to the amino‐ or carboxy terminus and studied the effects on MHC‐I up‐regulation and in vivo immunogenicity. Cystein and lysine contain reactive groups which are likely to influence the binding of modified peptides into the antigen‐binding groove of Db. These small modifications of the optimal 9‐mer peptide strongly influenced their functions but still there was a correlation between MHC‐I up‐regulation and CTL responses. Up‐regulation of MHC‐I in vitro may reflect a capacity of peptides to accumulate on the surface of particular antigen‐presenting cells in vivo.

AB - Cytotoxic T lymphocytes (CTL) recognize target antigens as short peptides presented by major histocompatibility complex class I molecules (MHC‐I). Externally added peptides can sensitize target cells by binding directly to MHC‐I without any need for internal processing. Those which are similar in length to endogenously processed peptides are more potent in this respect than slightly longer peptides. Peptide MHC‐I interactions can also be reflected as upregulation of MHC‐I in vitro on certain cells. We have compared the capacity of Db, Kb‐ and Ld‐binding peptides, which are slightly different in length, to up‐regulate MHC‐I in vitro with their immunogenicity in vivo, in relation to generation of CTL responses. A clear correlation between these two different functions was found. We have also modified a 9‐mer Db‐binding peptide by adding cystein to the amino terminus and lysine to the amino‐ or carboxy terminus and studied the effects on MHC‐I up‐regulation and in vivo immunogenicity. Cystein and lysine contain reactive groups which are likely to influence the binding of modified peptides into the antigen‐binding groove of Db. These small modifications of the optimal 9‐mer peptide strongly influenced their functions but still there was a correlation between MHC‐I up‐regulation and CTL responses. Up‐regulation of MHC‐I in vitro may reflect a capacity of peptides to accumulate on the surface of particular antigen‐presenting cells in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0026494880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026494880&partnerID=8YFLogxK

U2 - 10.1002/eji.1830221209

DO - 10.1002/eji.1830221209

M3 - Article

C2 - 1446701

AN - SCOPUS:0026494880

VL - 22

SP - 3085

EP - 3090

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 12

ER -